UBS Maintains a 'Neutral' on Omega Healthcare Investors (OHI); SNF NF Storm Clouds Parting
OHI Hot Sheet
Rating Summary:2 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 7 | New: 26
UBS maintains a 'Neutral' on Omega Healthcare Investors (NYSE: OHI) price target raised from $17 to $21.
UBS analyst says, "Better cost mitigation bringing clearer skies to CMS storm clouds: TTM EBITDAR / rent coverage (as of Sept. 30th ) was flat q/q at 1.8x. However, the impact of last Fall’s 11.1% Medicare cuts will begin to felt in Q1 results. While initial expectations called for a ~40bp reduction to coverage, we are encouraged by OHI’s observations of better cost mitigation in Oct/Nov which should mitigate the impact. That said, EBITDAR / rent coverage could slide a bit lower in 2013 when the additional 2% Medicare rate cuts are enacted. Further, we note OHI’s proforma coverage metrics do not fully include future contractual rent escalators...Our new ‘12/’13 FFO estimates of $2.07/$2.15 (from $1.94/$2.07) reflect higher investment activity."
For an analyst ratings summary and ratings history on Omega Healthcare Investors click here. For more ratings news on Omega Healthcare Investors click here.
Shares of Omega Healthcare Investors closed at $21.93 yesterday, with a 52 week range of $14.40-$24.46.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
UBS analyst says, "Better cost mitigation bringing clearer skies to CMS storm clouds: TTM EBITDAR / rent coverage (as of Sept. 30th ) was flat q/q at 1.8x. However, the impact of last Fall’s 11.1% Medicare cuts will begin to felt in Q1 results. While initial expectations called for a ~40bp reduction to coverage, we are encouraged by OHI’s observations of better cost mitigation in Oct/Nov which should mitigate the impact. That said, EBITDAR / rent coverage could slide a bit lower in 2013 when the additional 2% Medicare rate cuts are enacted. Further, we note OHI’s proforma coverage metrics do not fully include future contractual rent escalators...Our new ‘12/’13 FFO estimates of $2.07/$2.15 (from $1.94/$2.07) reflect higher investment activity."
For an analyst ratings summary and ratings history on Omega Healthcare Investors click here. For more ratings news on Omega Healthcare Investors click here.
Shares of Omega Healthcare Investors closed at $21.93 yesterday, with a 52 week range of $14.40-$24.46.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); Reducing Estimates and PT
- UBS Maintains a 'Buy' on Express Inc. (EXPR); A Misstep, But Still A Consistent Performer
- Goldman Sachs Boosts Target on Williams-Sonoma (WSM) On Signs of Stabilization
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
